基本信息
浏览量:0
职业迁徙
个人简介
I obtained an MSc in Bio-Nanotechnology at the University of Sheffield followed by a PhD in the Leukaemic Stem Cell group at Newcastle University. The PhD project focused on targeting leukaemic fusion genes in vivo using chemically modified oligonucleotides. My current postdoctoral work focuses on oligonucleotide delivery in vivo, gene editing in haematopoietic stem cells, and the molecular mechanisms of leukaemogenesis in Down syndrome myeloid leukaemia.
研究兴趣
论文共 35 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
KLINISCHE PADIATRIEno. 3 (2024): 201-202
Mi K. Trinh, Matthew D. Young, Conor Parks, Agnes Oszlanczi, Toochi Ogbonnah, Di Zhou,Angus Hodder,Konstantin Schuschel,Hasan Issa,Laura Jardine, Jan-Henning Klusmann, Jack Bartram,Sam Behjati
CANCER RESEARCHno. 17 (2024)
KLINISCHE PADIATRIEno. 3 (2024): 216-216
Mi K. Trinh,Matthew D. Young, Conor Parks,Agnes Oszlanczi, Toochi Ogbonnah, Di Zhou,Angus Hodder,Konstantin Schuschel,Hasan Issa,Laura Jardine,Jan-Henning Klusmann,Jack Bartram,Sam Behjati
Cancer Researchno. 17_Supplement (2024)
L N Cifarelli,Hasan Issa,Ludovica Proietti,Konstantin Schuschel, Katja Menge,Lucie Gack,Christian Ihling,Andrea Sinz,Florian Grebien, Jan‐Henning Klusmann,Dirk Heckl
Klinische Pädiatrie (2024)
ISCIENCEno. 10 (2023)
Leukemiano. 4 (2023): 820-834
Luca Nunzio Cifarelli,Hasan Issa,Konstantin Schuschel, Katja Menge,Lucie Gack,Christian Ihling,Andrea Sinz,Jan-Henning Klusmann,Dirk Heckl
Bloodno. Supplement 1 (2023): 711-711
HemaSphereno. S3 (2023)
HemaSphereno. S3 (2023): e9193694-e9193694
加载更多
作者统计
#Papers: 35
#Citation: 118
H-Index: 5
G-Index: 8
Sociability: 5
Diversity: 1
Activity: 7
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn